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First-pass contrast-enhanced myocardial perfusion MRI in
rodents has so far not been possible due to the temporal and
spatial resolution requirements. We developed a new first-
pass perfusion MR method for rodent imaging on a clinical
3.0-T scanner (Philips Healthcare, Best, The Netherlands) that
employed 10-fold k-space and time domain undersampling
with constrained image reconstruction, using temporal basis
sets (k-t principle component analysis) to achieve a spatial re-
solution of 0.2 3 0.2 3 1.5mm
3 and an acquisition window of
43 msec. The method was successfully tested in five healthy
and four infarcted mice (C57BL/6J) at heart rates of 495.1 6
45.8 beats/min. Signal-intensity-time profiles showed a per-
centage myocardial signal increase of 141.3 6 38.9% in nor-
mal mice, compared with 44.7 6 32.4% in infarcted segments.
Mean myocardial blood flow by Fermi function for constrained
deconvolution in control mice was 7.3 6 1.5 mL/g/min, com-
parable to published literature, with no significant differences
between three myocardial segments. In infarcted segments,
myocardial blood flow was significantly reduced to 1.2 6 0.8
mL/g/min (P < 0.01). This is the first report of first-pass myo-
cardial perfusion MR in a mouse model on a clinical 3-T MR
scanner and using a k-t undersampling method. Data were
acquired on a 3-T scanner, using an approach similar to clini-
cal acquisition protocols, thus facilitating translation of imag-
ing findings between rodent and human studies. Magn
Reson Med 64:1592–1598, 2010. V C 2010 Wiley-Liss, Inc.
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Genetically modified mice are increasingly used to study
the pathophysiology of cardiovascular disease (1–4). One
of the most relevant readouts in cardiovascular disease is
myocardial blood flow (MBF), which is altered in several
disease processes, including atherosclerosis, systemic
hypertension, and diabetes mellitus (5–7). Therefore, accu-
rate noninvasive assessment of MBF in rodent models of
cardiovascular disease is highly desirable. Currently, such
measurements may be obtained in rodents with nuclear
perfusion imaging, echocardiography, microspheres, and
spin labeling MRI (8–12). However, nuclear and echocar-
diographic perfusion methods are limited by relatively low
spatial resolution. Microspheres prohibit serial assessment
from the same animal, and concerns have been raised about
the validity of microsphere measurements in rodents (13).
In principle, MR offers high spatial resolution and tissue
contrast and is therefore an attractive method for rodent
imaging. Compared with larger animal models or human
imaging, however, rodent MR is challenging because of the
very high heart rates that are encountered (up to 600 beats/
min) and the required high spatial resolution of  0.2mm
voxel width in-plane. Spin labeling MR methods have been
proposed for myocardial perfusion imaging in rodents, but
these techniques require acquisition times of  25 min for a
single slice, thus making it difficult to incorporate them in
more complex imaging protocols (10).
In humans, the preferred method for myocardial perfu-
sion assessment is dynamic first-pass contrast-enhanced
acquisition. The method has been well validated in clini-
cal models (7). However, first-pass perfusion assessment
requires acquisition of a complete image at each or every
second heartbeat and within a short acquisition window,
following a magnetization preparation pulse. At the heart
rates and required spatial resolution in rodents, first-pass
contrast-enhanced perfusion MRI has been considered
not feasible with conventional acquisition methods.
Over the past several years, methods that exploit spatio-
temporal data correlations such as k-space and time do-
main undersampling [k-t sensitivity encoding (k-t SENSE)]
have been developed, achieving acceleration of data acqui-
sition by up to a factor of 8 in clinical studies (14). Further
refinements of the original method, constrained image
reconstruction using temporal basis sets [k-t principle
component analysis (k-t PCA)] permit even higher acceler-
ation factors, with fewer training profiles and improved
temporal fidelity (15). With these methods, it may become
feasible to perform first-pass contrast-enhanced myocardial
perfusion imaging in rodents. The purpose of this study
was to develop and show feasibility of first-pass contrast-
enhanced myocardial perfusion cardiovascular magnetic
resonance (CMR) in a rodent model at 3.0 T.
MATERIALS AND METHODS
Pulse Sequence Design
The myocardial perfusion method was implemented on
a clinical 3.0-T system (Achieva; Philips Healthcare,
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on a method previously used for human application (14)
and adapted to the required field of view and temporal
resolution in mice. A custom-written software patch
allowed triggering of the scanner to a heart rate of up to
600 beats/min. Pulse sequence parameters were as fol-
lows: saturation recovery gradient echo mode, pulse rep-
etition time/echo time 6.7 msec/1.0 msec, flip angle 20 ,
10-fold undersampling with three training profiles, par-
tial Fourier acquisition, one slice acquired during each
RR interval, field of view 25   25mm
2, slice thickness
1.5mm, matrix 128   128, spatial resolution 0.2  
0.2mm
2 (reconstructed to 0.13   0.13mm
2), preparation
pulse delay 100 msec, acquisition window 43 msec). To
improve temporal fidelity of the data at the high under-
sampling factors used, the k-t PCA method was used for
image reconstruction (15).
Mouse Imaging
Animal Model
Nine 10- to 12-week-old homozygous C57BL/6J male
mice were acquired from Charles Rivers Laboratories
(Edinburgh, UK) or were bred within the Animal Unit of
the Rayne Institute at King’s College London. The hous-
ing and care of the animals and all the procedures used
in these studies were performed in accordance with the
guidelines and regulations of the United Kingdom Home
Office. Five animals served as healthy controls, and in
four animals permanent myocardial infarction was
induced 3 days prior to imaging. For the induction of
myocardial infarctions, mice were anesthetized by iso-
flurane inhalation and ventilated by tracheal intubation.
Following left-side lateral thoracotomy, an 8-0 nylon
suture was carefully placed around the left anterior de-
scending coronary artery and was tied by the edge of the
left atrium.
After the completion of the imaging study, 300 mLo f
Evans Blue (2% w/v) was injected into the tail vein to
delineate the area at risk and the animals were sacri-
ficed. Hearts were excised, mounted in agarose, and
sliced into 1.5mm sections from apex to base. Slices
were fixed overnight in 10% formaldehyde and were
then digitally imaged, using a high-resolution optical
scanner. Areas stained negative for Evans Blue were
defined as not perfused and thus to be perfusion territory
of the ligated coronary artery. Locations were identified
as septal, anterolateral, and inferolateral, as described for
perfusion MRI. Areas stained positive for Evans Blue
were considered remote zones.
Preparation and Sedation
Mice were anesthetized and maintained under inhala-
tional anesthesia via nose cone (1.4% isoflurane/oxygen).
Rectal temperature was monitored continuously and a
warm air flow (using an MR-compatible heater system;
SA Instruments, Stony Brook, NY) was adapted to main-
tain temperature at 37 C. For reliable electrocardiogram
(ECG) synchronization and artifact-free high-resolution
imaging, a dedicated small-animal ECG device, 1025-MR
(SA Instruments), and dedicated microscopy receive
coils (23mm diameter, single circular loop; Philips
Healthcare) were used (Fig. 1a). Two ECG leads were
placed subcutaneously on the left and right side of the
thorax.
MRI
All data were acquired during free breathing of the ani-
mal. For localization of the heart, a low-resolution gradi-
ent echo scout scan was acquired in the coronal and
transverse orientations, using the following parameters:
field of view 300   300mm
2, matrix 300   300, slice
thickness 2mm, pulse repetition time/echo time 20/5.8
msec, flip angle 20 , number of slices nine. Subse-
quently, pseudo two- and four-chamber gradient echo
cine scans were acquired with prospective ECG-triggered
spoiled gradient echo sequences. Imaging parameters
were field of view 70   70mm, matrix 224, slice thick-
ness 1.5mm, pulse repetition time/echo time 14/5.3
msec, flip angle 30 , two lines/RR interval, temporal re-
solution 18 msec. High-resolution (0.2   0.2   1mm
3)
short-axis, two- and four- chamber (biplane) views were
then planned on those views. Imaging parameters were
field of view 35   35mm
2, matrix 160, slice thickness
1mm, pulse repetition time/echo time 11/5.3 msec, flip
angle 20 , one line/RR interval, temporal resolution 11
msec, number of signal averages two. These images
allowed for planning of the true short-axis views of the
left ventricle. Perfusion imaging was performed in mid-
ventricular short-axis orientation, using the pulse
sequence described above.
FIG. 1. a: Design and dimensions of the single circular loop microscopy coil with respect to mice used for myocardial perfusion imag-
ing. b: Diagram of the three-segment model used for analysis of MBF in mice. The myocardium was divided into three equidistant sec-
tors of equal circumferential extent along the myocardial centerline, starting from a reference point placed at the anterior septal
insertion of the right ventricle.
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A catheter was placed in the tail vein of the mouse and
0.1 mmol/kg bodyweight Gadolinium Gadopentetate
Dimeglumine (Gd-DTPA) (Magnevist, Schering, Ger-
many) was injected after the perfusion scan was started.
To ensure a reproducible bolus injection, the contrast
agent, as well as 25 mL of saline, was preloaded into
small-bore tetrafluoroethylene tubing and injected man-
ually over 3 sec.
Data Analysis
Semiquantitative analysis was performed using dedi-
cated image analysis software (Mass 7.1, Medis; Leiden
University, Leiden, The Netherlands). Endocardial and
epicardial contours were drawn on images with best
blood to myocardium contrast and copied to all other
dynamic images. The position of individual contours
was then manually corrected to account for respiratory
motion. The myocardium was divided into three sectors
of equal circumferential extent along the myocardial cen-
terline, starting from a reference point placed at the ante-
rior septal insertion of the right ventricle (Fig. 1b).
To obtain the arterial input function, a region of inter-
est was drawn inside the left ventricular (LV) blood
pool. Signal intensity (SI)/time curves were generated for
the LV blood pool, for the myocardium as a whole, and
for the three myocardial sectors. The maximal upslope of
the profiles was generated using five-point fitting. SI pro-
files were then generated for each sector and the region
of interest in the LV blood pool. Enhancement ratio of
signal increase and normalized SI upslope ratios
between the blood pool and myocardium were calculated
as (enhancement ratio ¼ (SI max – SI baseline)/SI base-
line) and (normalized SI upslope ¼ upslope myocar-
dium/LV).
In addition to this semiquantitative upslope-based
analysis, absolute MBF was computed from the LV blood
pool and myocardial tissue SI vs. time curves, using
Fermi constrained deconvolution (16,17). The deconvo-
lution algorithm was implemented in-house in
MATLABV R (The MathWorks, Inc., Novi, MI), for the
analysis of the data derived from the Mass image analy-
sis software. The curves were baseline corrected and
cropped to the first pass only (16,17).
Statistics
Continuous data were expressed as mean 6 standard
deviation. For comparing groups (>2), the analysis of
variance test was used, and for comparing pairs of a
group, Tukey’s test was used. Statistical significance was
considered for P < 0.05 and high significance was con-
sidered for P < 0.01.
RESULTS
Myocardial infarcts were successfully induced in the
four operated mice. In the midventricular slice that was
investigated by perfusion imaging, all infarcts were local-
ized in the anterolateral myocardial segment. All areas
stained negative for Evans Blue matched with the MR
perfusion defect.
First-pass myocardial perfusion imaging was success-
fully performed in all five control and the four infarcted
mice. All mice tolerated the scanning without any com-
plications. The observed heart rate was within the
expected physiological range, with no significant hemo-
dynamic effect from the anesthetic observed. There was
no significant difference in heart rate between the two
groups (control group: 485 6 50 beats/min, infarcted
group 509 6 45 beats/min, P > 0.05).
Typical transient subendocardial dark rim artifacts
were noted in three animals, affecting in particular the
inferolateral segments (Fig. 2). These banding artifacts
persisted for three to seven heartbeats during peak signal
in the LV and affected 30–60% of the myocardial thick-
ness. However, artifacts did not affect semiquantitative
and quantitative measurements.
FIG. 2. Series of dynamic images after contrast bolus injection (0.1 mmol/kg body weight Gd-DTPA) in one control mouse. Images dem-
onstrate the baseline scan (a), as well as the passage of the contrast agent in the RV ((b), arrowhead), LV ((c), arrowhead), and gradually
in the myocardium ((d–g), arrowhead). Note transient dark banding artifact in the inferior wall (arrows, (f,g)).
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SI/phase profiles derived from control and left anterior
descending infarcted mice (Figs. 3–5) showed similar
features to human profiles. In control mice, LV signal
increased from 293.8 6 69.1 before contrast delivery to a
peak of 2148.8 6 570.5, resulting in an enhancement ra-
tio of 6.32 6 0.98. Myocardial signal increased from
290.8 6 63.3 to 694.8 6 154.9, with an enhancement ra-
tio of 1.41 6 0.39 (Fig. 6). The normalized SI upslope in
normal segments was 7.8 6 2.3. The mean estimated
MBF by Fermi-constrained deconvolution in all myocar-
dial segments in control mice was 7.3 6 1.5 mL/g/min.
There were no significant differences between the three
segments: septum (7.4 6 1.7 mL/g/min), anterolateral
wall (6.7 6 1.5 mL/g/min), and inferolateral wall (7.8 6
1.2 mL/g/min; P > 0.05).
In all infarcted mice, perfusion defects due to the myo-
cardial infarction were localized in the anterolateral seg-
ment, matching the infarct location on histology (see Fig.
3). In infarcted mice, an enhancement ratio of 6.30 6
0.56 (SI baseline: 380.8 6 59.8; SI max: 2754.5 6 215.3)
was measured in the LV. In remote myocardial segments,
the enhancement ratio was 1.74 6 0.64 (SI baseline:
359.0 6 147.9; SI max: 969.5 6 44.7), while in the
infarcted anterolateral segments, the mean enhancement
ratio was only 0.45 6 0.32 (P < 0.01) (SI baseline: 376.0
6 129.2; SI max: 543.5 6 35.4; Fig. 6). The normalized
SI upslope in remote segments was 6.2 6 3.0 versus 2.9
6 1.1 in infarcted segments (P < 0.01). Estimated MBF
differed significantly between normal and infarct seg-
ments (7.1 6 1.5 vs. 1.2 6 0.8 mL/g/min; P < 0.01;
Fig. 7).
DISCUSSION
This study is the first full report of first-pass contrast-
enhanced MR myocardial perfusion imaging in mice. A
previous account of bolus perfusion in mice on a small-
bore, high-field MR system has recently been published
in a conference proceeding (18). The present work is, to
our knowledge, the first report of first-pass myocardial
perfusion CMR in a mouse model on a clinical MR scan-
ner and using a k-t undersampling method. The pro-
posed method offers several potential improvements over
previously used spin-labeling MR methods for myocar-
dial perfusion imaging in rodents, in particular, faster
data acquisition and closer correlation with clinically
used imaging protocols.
The first-pass contrast-enhanced myocardial perfusion
imaging protocol used in this study was based on highly
accelerated data acquisition with the k-t PCA method.
Thereby, high spatial resolution (0.2mm in-plane) and
high temporal resolution (43 msec) imaging with accu-
rate depiction of signal enhancements in the blood pools
and in the myocardium was possible. Relative to previ-
ous k-t SENSE protocols for human application (10), a
higher acceleration factor (10 vs. 5–8) was necessary and
a lower number of training profiles had to be used to
achieve the required acquisition speed. The k-t PCA
framework for image reconstruction has been shown to
improve temporal fidelity and thus permit robust meas-
urements of myocardial perfusion at very high
FIG. 3. Series of key dynamic images after contrast bolus injection comparing one control (a–e) and one infarcted mouse (f–j). Image
demonstrates the baseline (a,f) scans, the passage of the contrast agent in the RV (arrow, (b,g)), LV (arrow, (c,h)), and the myocardium
(d,i). Note the attenuated signal in the anterior wall of the infarcted mouse (i). Images on the right (e,j) represent matched Evans Blue
sections (2% w/v, injection into the tail vein) to delineate the area at risk. Note colocalization of the large anterior perfusion defect, using
MRI with decreased staining in the matched Evans Blue section (i,j).
FIG. 4. SI/phase profile from one control mouse. The dotted line
represents the passage of the contrast agent (CA) in the LV cavity.
The continuous lines represent the passage of the CA in the three
different segments of the myocardium.
Myocardial Perfusion MR in Mice 1595acceleration factors and with very few training profiles
(15). In the present study, it also proved robust to respi-
ratory motion, and despite the free-breathing experimen-
tal setup no apparent image artifacts relating to respira-
tion were observed. In k-t PCA, temporal basis functions
are derived based on the low-resolution training data
acquired in every heartbeat. These basis functions will
reflect significant respiratory-related bulk motion.
Accordingly, image artifacts from respiratory motion are
considerably reduced compared with k-t Broad-use Lin-
ear Acquisition Speed-up Technique (BLAST) and k-t
SENSE reconstructions. Moreover, respiratory excursions
of the anesthetized animals were shallow and relatively
regular, which may have helped to minimize artifacts.
In this study, signal-time intensity profiles did not
show signs of temporal low-pass filtering, and the calcu-
lated MBFs were comparable to that of published litera-
ture from arterial spin labeling and microsphere data (8–
10,19). Infarcted segments demonstrated significantly
reduced perfusion values, as expected.
Data in this study were acquired on a clinical 3-T
CMR scanner, using an approach that closely resembles
clinical acquisition protocols and thus facilitating clini-
cal translation of imaging findings. Increasingly, rodent
imaging is performed on clinical CMR systems (20)
because these systems offer sophisticated acquisition
protocols and off-the-shelf quantitative postprocessing
methods, but field strength and gradient performance are
lower compared with that of small-bore high-field mag-
nets. High-field (> 4.7 T) small-animal systems provide
the advantage of increased signal-to-noise ratio and spa-
tial and temporal resolution, but the limited availability
of novel acquisition and reconstruction methods may be
a drawback. The previous conference report of myocar-
dial perfusion on a dedicated 7-T high-field system
yielded spatial and similar temporal resolution identical
to that inour setup (18). However, findings made on
dedicated preclinical systems may be difficult to trans-
late into clinical practice due to the differences in field
strength and system specifics, a limitation that applies
much less if rodent scans are performed on clinical
scanners.
Cardiovascular MR has been shown to hold potential
for a comprehensive workup of cardiac function in
rodents. Global and regional cardiac function can be
quantified accurately with cine and tagging MR methods
FIG. 5. SI/phase profiles of one control (a) and one infarcted mouse (b) represent the passage of the CA in the myocardium (LV profile
is not displayed). Note especially the light-grey line ((b), arrows), which represents the attenuated passage of the contrast agent in the
anterolateral wall after myocardial infarction (anterolateral segments).
FIG. 6. Graphical representation of the enhancement ratio in signal increase ((SI max – SI baseline)/SI baseline) averages and standard
deviations in control mice, as well as in mice after myocardial infarction. A significantly lower enhancement ratio was found in the ante-
rior segments of the mice after permanent occlusion of the left anterior descending (P < 0.05) compared with the remote myocardium.
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visualized using late gadolinium-enhanced MR acquisi-
tion (22,23). In addition, imaging of metabolic and mo-
lecular processes in heart disease is an emerging field
and tremendous progress has been made in the last dec-
ade (24,25). The possibility to assess myocardial perfu-
sion would add an important additional readout. Con-
trast-enhanced myocardial perfusion MR integrates well
into such protocols because data acquisition is fast and
the administered contrast agent is used for subsequent
late gadolinium-enhanced imaging.
Limitations
Contrast delivery in this study was manual but can in
principle be automated to improve reproducibility. The
optimal contrast dose and injection speed need to be
optimized to account for physiological differences
between rodents and humans. The current implementa-
tion only allows for the acquisition of one slice at each
RR interval. More slices could potentially be acquired if
acquisitions were shared between multiple RR intervals
at the expense of lower temporal resolution or with fur-
ther refinements of the acquisition protocol. Finally, the
ability to acquire first-pass myocardial perfusion MR
data during vasodilator stress needs to be tested and
validated.
CONCLUSIONS
We present a novel approach for first-pass myocardial
perfusion MRI in rodents that provides MBF values
within the expected range in normal and left anterior de-
scending infarcted mice. The method is fast and may
permit data acquisition under pharmacological stress.
With the increasing range of mouse models in cardiovas-
cular disease, this method could provide a useful tool to
systematically investigate the role of ischemia in athero-
sclerosis, diabetes, hypertension, or heart failure.
REFERENCES
1. Arber S, Hunter JJ, Ross J Jr, Hongo M, Sansig G, Borg J, Perriard JC,
Chien KR, Caroni P. MLP-deficient mice exhibit a disruption of car-
diac cytoarchitectural organization, dilated cardiomyopathy, and
heart failure. Cell 1997;88:393–403.
2. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano
CA, Lefkowitz RJ. Cardiac function in mice overexpressing the beta-
adrenergic receptor kinase or a beta ARK inhibitor. Science 1995;
268:1350–1353.
3. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen
FJ, Seidman CE, Seidman JG. A mouse model of familial hyper-
trophic cardiomyopathy. Science 1996;272:731–734.
4. Gilson WD, Yang Z, French BA, Epstein FH. Measurement of myo-
cardial mechanics in mice before and after infarction using multi-
slice displacement-encoded MRI with 3D motion encoding. Am J
Physiol Heart Circ Physiol 2005;288:H1491–1497.
5. Strauer BE, Motz W, Vogt M, Schwartzkopff B. Impaired coronary
flow reserve in NIDDM: a possible role for diabetic cardiopathy in
humans. Diabetes 1997;46(suppl 2):S119–124.
6. Laine H, Raitakari OT, Niinikoski H, Pitkanen OP, Iida H, Viikari J,
Nuutila P, Knuuti J. Early impairment of coronary flow reserve in
young men with borderline hypertension. J Am Coll Cardiol 1998;32:
147–153.
7. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR,
Marincek B, Luscher TF, von Schulthess GK. Assessment of myocar-
dial perfusion in coronary artery disease by magnetic resonance: a
comparison with positron emission tomography and coronary angiog-
raphy. Circulation 2001;103:2230–2235.
8. Richer C, Domergue V, Gervais M, Bruneval P, Giudicelli JF. Fluo-
spheres for cardiovascular phenotyping genetically modified mice.
J Cardiovasc Pharmacol 2000;36:396–404.
9. Raher MJ, Thibault H, Poh KK, Liu R, Halpern EF, Derumeaux G,
Ichinose F, Zapol WM, Bloch KD, Picard MH, Scherrer-Crosbie M. In
vivo characterization of murine myocardial perfusion with myocar-
dial contrast echocardiography: validation and application in nitric
oxide synthase 3 deficient mice. Circulation 2007;116:1250–1257.
10. Kober F, Iltis I, Cozzone PJ, Bernard M. Myocardial blood flow map-
ping in mice using high-resolution spin labeling magnetic resonance
imaging: influence of ketamine/xylazine and isoflurane anesthesia.
Magn Reson Med 2005;53:601–606.
11. Hirai T, Nohara R, Hosokawa R, Tanaka M, Inada H, Fujibayashi Y,
Fujita M, Konishi J, Sasayama S. Evaluation of myocardial infarct
size in rat heart by pinhole SPECT. J Nucl Cardiol 2000;7:107–111.
12. Barbee RW, Perry BD, Re RN, Murgo JP. Microsphere and dilution
techniques for the determination of blood flows and volumes in con-
scious mice. Am J Physiol 1992;263(3 pt 2):R728–733.
13. Buckberg GD, Luck JC, Payne DB, Hoffman JI, Archie JP, Fixler DE.
Some sources of error in measuring regional blood flow with radioac-
tive microspheres. J Appl Physiol 1971;31:598–604.
FIG. 7. Graphical representation of regional MBF group averages and standard deviations in control and infarcted mice. No significant
regional MBF variations could be found comparing the different segments in the control mice. However, a significantly lower MBF was
found in the anterolateral segments of the infarcted mice (*, P < 0.05) compared with the inferolateral and septal segments.
Myocardial Perfusion MR in Mice 159714. Plein S, Ryf S, Schwitter J, Radjenovic A, Boesiger P, Kozerke S.
Dynamic contrast-enhanced myocardial perfusion MRI accelerated
with k-t sense. Magn Reson Med 2007;58:777–785.
15. Pedersen H, Kozerke S, Ringgaard S, Nehrke K, Kim WY. k-t PCA:
temporally constrained k-t BLAST reconstruction using principal
component analysis. Magn Reson Med 2009;62:706–716.
16. Jerosch-Herold M, Wilke N, Stillman AE. Magnetic resonance quanti-
fication of the myocardial perfusion reserve with a Fermi function
model for constrained deconvolution. Med Phys 1998;25:73–84.
17. Jerosch-Herold M, Swingen C, Seethamraju RT. Myocardial blood
flow quantification with MRI by model-independent deconvolution.
Med Phys 2002;29:886–897.
18. Antkowiak P, Janiczek R, Gibberman L, Xu C, Kramer C, Meyer C,
French B, Epstein F. Quantitative first-pass perfusion MRI of the
mouse heart. J Cardiovasc Magn Reson 2010;12(suppl 1):M10.
19. Trabold F, Pons S, Hagege AA, Bloch-Faure M, Alhenc-Gelas F, Giu-
dicelli JF, Richer-Giudicelli C, Meneton P. Cardiovascular pheno-
types of kinin B2 receptor- and tissue kallikrein-deficient mice.
Hypertension 2002;40:90–95.
20. Gilson WD, Kraitchman DL. Cardiac magnetic resonance imagingin small
rodents using clinical 1.5 T and 3.0 T scanners. Methods 2007;43:35–45.
21. Young AA, French BA, Yang Z, Cowan BR, Gilson WD, Berr SS,
Kramer CM, Epstein FH. Reperfused myocardial infarction in mice:
3D mapping of late gadolinium enhancement and strain. J Cardiovasc
Magn Reson 2006;8:685–692.
22. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O,
Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed
contrast enhancement to irreversible injury, infarct age, and contract-
ile function. Circulation 1999;100:1992–2002.
23. Yang Z, Berr SS, Gilson W, Toufektsian MC, French BA. Simultane-
ous evaluation of infarct size and cardiac function in intact mice by
contrast-enhanced cardiac magnetic resonance imaging reveals con-
tractile dysfunction in noninfarcted regions early after myocardial in-
farction. Circulation 2004;109:1161–1167.
24. Sosnovik DE, Garanger E, Aikawa E, Nahrendorf M, Figuiredo JL, Dai
G, Reynolds F, Rosenzweig A, Weissleder R, Josephson L. Molecular
MRI of cardiomyocyte apoptosis with simultaneous delayed-enhance-
ment MRI distinguishes apoptotic and necrotic myocytes in vivo:
potential for midmyocardial salvage in acute ischemia. Circ Cardio-
vasc Imaging 2009;2:460–467.
25. Berr SS, Xu Y, Roy RJ, Kundu B, Williams MB, French BA. Images
in cardiovascular medicine: serial multimodality assessment of myo-
cardial infarction in mice using magnetic resonance imaging and
micro-positron emission tomography provides complementary infor-
mation on the progression of scar formation. Circulation 2007;115:
e428–429.
1598 Makowski et al.